A Real-world Comparison of Infection Rate and Lymphocyte Counts Among Relapsing: Remitting Multiple Sclerosis Patients 50 Years or Older Treated with Subcutaneous Interferon Beta-1a Or Dimethyl Fumarate

Subjects

Subjects :

Dimethyl fumarate
business.industry
Lymphocyte
Multiple sclerosis
Interferon beta-1a
General Medicine
medicine.disease
Infection rate
chemistry.chemical_compound
medicine.anatomical_structure
Neurology
Relapsing remitting
chemistry
Immunology
medicine
Neurology (clinical)
business
medicine.drug

Details

ISSN :

22110348

Volume :

26

Database :

OpenAIRE

Journal :

Multiple Sclerosis and Related Disorders

Accession number :

edsair.doi...........09961b5cd81eca7d407966b2bc045c1b

Full Text :

https://doi.org/10.1016/j.msard.2018.10.089